163 related articles for article (PubMed ID: 17653150)
1. California campuses resist industry restrictions.
Check E
Nature; 2007 Jul; 448(7152):394-5. PubMed ID: 17653150
[No Abstract] [Full Text] [Related]
2. California dreaming.
Nature; 2007 Jul; 448(7152):388. PubMed ID: 17653147
[No Abstract] [Full Text] [Related]
3. Need to strike balance with industry-academia rules.
Leuchter A; Levey GS
Nature; 2007 Oct; 449(7163):658. PubMed ID: 17928837
[No Abstract] [Full Text] [Related]
4. Industry and medicine: conflicting interests and the power of money.
Popovsky MA; Garcia N
Transfusion; 2007 Jun; 47(6):1098-9. PubMed ID: 17524103
[No Abstract] [Full Text] [Related]
5. NIH conflicts rules are not right for universities.
Korn D; Ehringhaus SH
Nature; 2005 Apr; 434(7035):821. PubMed ID: 15829935
[No Abstract] [Full Text] [Related]
6. More than one bad apple.
Nature; 2008 Oct; 455(7215):835. PubMed ID: 18923460
[TBL] [Abstract][Full Text] [Related]
7. Conflict of interest. Stung by controversy, biomedical groups urge consistent guidelines.
Kaiser J
Science; 2007 Jul; 317(5837):441. PubMed ID: 17656694
[No Abstract] [Full Text] [Related]
8. Out of sight, out of mind: how Harvard University exploited rural Chinese villagers for their DNA.
Keim B
Genewatch; 2003; 16(5):10-1. PubMed ID: 15025121
[No Abstract] [Full Text] [Related]
9. Resident and fellow section. Conflicts of interest between physicians and the pharmaceutical industry: focus on headache medicine.
Rubin EB; Bernat JL
Headache; 2008; 48(10):1545-9. PubMed ID: 19076654
[No Abstract] [Full Text] [Related]
10. Commentary: Addressing corporate influence through ethical guidelines.
Greenland S
Int J Epidemiol; 2008 Feb; 37(1):57-9; discussion 65-8. PubMed ID: 18245052
[No Abstract] [Full Text] [Related]
11. Restrictions on business relationships with industries, and their unintended adverse consequences.
Sataloff RT
Ear Nose Throat J; 2009 May; 88(5):904-8. PubMed ID: 19444783
[No Abstract] [Full Text] [Related]
12. Industry and the academy: conflicts of interest in contemporary health research.
Downie J; Baird P; Thompson J
Health Law J; 2002; 10():103-22. PubMed ID: 14748274
[No Abstract] [Full Text] [Related]
13. Pharma buys a conscience.
Elliott C
Am Prospect; 2001 Sep 24-Oct 8; 12(17):16-20. PubMed ID: 16184653
[No Abstract] [Full Text] [Related]
14. [The influence of the pharmaceutical industry on treatment guidelines].
Kramers C; Wuis E; Schouwenberg B
Ned Tijdschr Geneeskd; 2008 Jan; 152(2):114; author reply 114. PubMed ID: 18265803
[No Abstract] [Full Text] [Related]
15. Transparency urged over research payments.
Check E
Nature; 2007 Aug; 448(7155):738. PubMed ID: 17700667
[No Abstract] [Full Text] [Related]
16. Institutes in pharma cash probe.
Ledford H
Nature; 2008 Jun; 453(7198):963. PubMed ID: 18563109
[No Abstract] [Full Text] [Related]
17. Trust, but verify.
Nature; 2009 Sep; 461(7262):315. PubMed ID: 19759574
[No Abstract] [Full Text] [Related]
18. [Medical research and the pharmaceutical industry. Uneasy bedfellows or a prenuptial agreement?].
Schuling J
Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1909. PubMed ID: 11605317
[No Abstract] [Full Text] [Related]
19. Conflict of interest in industry-sponsored drug development.
Emanuel EJ
Clin Adv Hematol Oncol; 2007 Apr; 5(4):265-7. PubMed ID: 17607285
[No Abstract] [Full Text] [Related]
20. Is there a crisis of accountability in the American research university?
Smith BL; Korn D
Minerva; 2000; 38(2):129-45. PubMed ID: 17152687
[No Abstract] [Full Text] [Related]
[Next] [New Search]
